Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse

Completed · Not applicable

Conditions studied: Toxoplasmosis, Cerebral, HIV Infections

In brief

To compare pyrimethamine and intravenous (IV) clindamycin vs. pyrimethamine and sulfonamides in the treatment of AIDS patients with central nervous system (CNS) Toxoplasma gondii.

Key facts

Study ID

NCT00002064

Run by

Palo Alto Medical Foundation

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Co-existing Condition:
• Patients with the following conditions are excluded:
• Opportunistic infection (Pneumocystis carinii pneumonia (PCP), cryptococcal meningitis) or other conditions (brain abscess) which would make treatment results difficult to interpret due to concurrent infection, disease, or therapy.
• Patients with other opportunistic infections or brain diseases are excluded.
• Patients with AIDS and cerebral toxoplasmosis.

Where it is running

• Palo Alto Med Foundation — Palo Alto, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.